Skip to main content

Table 2 Response of participants to the 4-item Medication Adherence Questions (MAQ) at baseline and 6-month post-baseline

From: Pharmacist-led intervention in treatment non-adherence and associated direct costs of management among ambulatory patients with type 2 diabetes in southwestern Nigeria

Items Control (n = 95)   Mc Nemar test Intervention (n = 106) Mc Nemar test
Baseline 6-month post baseline p-value Baseline 6-month post baseline p-value
Yes n(%) No
n (%)
Yes
n (%)
No n(%)   Yes n(%) No
n(%)
Yes n(%) No
n(%)
 
1. Are there times when you forget to take your DM/HHDx medicine(s)? 8 (8.4) 88 (92.6) 5 (5.3) 90 (94.7) 0.219 15 (14.2) 91 (85.8) 8 (7.5) 98 (92.5) 0.017*
2. Do you have problems remembering to take your DM/HHDx medication(s) in past few weeks? 17 (17.9) 78 (82.1) 14 (14.7) 91 (95.8) 0.607 36(34.0) 70 (66.0) 12(11.3) 94 (88.7) 0.000*
3. Are there times when you feel much better and you discontinue your DM/HHDx medicine(s)? 4 (4.2) 91 (95.8) 1 (1.1) 94 (98.9) 0.25 5 (4.7) 101 (95.3) 2 (1.9) 104 (98.1) 1.00
4. Are there times when you feel uncomfortable with your medicine(s) and you stop taking them? 3 (3.2) 92 (96.8) 4 (4.2) 91 (95.8) 1.00 4 (3.8) 102 (96.2) 2 (1.9) 104 (98.1) 0.687
  1. HHDX: Hypertensive Heart Disease; Control group - HbA1c < 7.0%; Intervention group - HbA1c ≥ 7%. A ‘No’ response to all the 4-item questions was considered as total (100%) commitment to medication-taking/adherence, while a ‘Yes’ response to any of the 4-item questions indicated suboptimal (< 100%) adherence. *Significant difference with McNemar test, Level of significant p < 0.05